2-(5-((2-((1H-benzo[d]imidazol-2-yl)amino)-2-oxoethyl)thio)-4H-1,2,4-triazol-3-yl)benzoic acid

ID: ALA3577962

Chembl Id: CHEMBL3577962

PubChem CID: 122178132

Max Phase: Preclinical

Molecular Formula: C18H14N6O3S

Molecular Weight: 394.42

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CSc1nnc(-c2ccccc2C(=O)O)[nH]1)Nc1nc2ccccc2[nH]1

Standard InChI:  InChI=1S/C18H14N6O3S/c25-14(21-17-19-12-7-3-4-8-13(12)20-17)9-28-18-22-15(23-24-18)10-5-1-2-6-11(10)16(26)27/h1-8H,9H2,(H,26,27)(H,22,23,24)(H2,19,20,21,25)

Standard InChI Key:  MWUOXWJZZXSQFY-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3577962

    ---

Associated Targets(non-human)

ccrA Beta-lactamase type II (170 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Beta-lactamase L1 (242 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
imiS Beta-lactamase (27 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
spm-1 Beta-lactamase IMP-1 (38 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.42Molecular Weight (Monoisotopic): 394.0848AlogP: 2.78#Rotatable Bonds: 6
Polar Surface Area: 136.65Molecular Species: ACIDHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.30CX Basic pKa: 2.49CX LogP: 2.11CX LogD: -1.05
Aromatic Rings: 4Heavy Atoms: 28QED Weighted: 0.37Np Likeness Score: -1.60

References

1. Yang SK, Kang JS, Oelschlaeger P, Yang KW..  (2015)  Azolylthioacetamide: A Highly Promising Scaffold for the Development of Metallo-β-lactamase Inhibitors.,  (4): [PMID:25893049] [10.1021/ml500534c]

Source